Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma
暂无分享,去创建一个
G. Morgan | W. Gregory | F. Ross | F. Davies | G. Jackson | M. Kaiser | M. Cavo | R. Owen | Ping Wu | C. Pawlyn | A. Brioli | G. Jackson